Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Elephantiasis, Filarial | 9 | 2021 | 47 | 4.33 | Why? |
| Mass Drug Administration | 9 | 2021 | 143 | 2.54 | Why? |
| Tropical Medicine | 3 | 2021 | 237 | 2.03 | Why? |
| Trachoma | 4 | 2021 | 48 | 1.96 | Why? |
| Neglected Diseases | 7 | 2021 | 381 | 1.79 | Why? |
| Anthelmintics | 4 | 2018 | 104 | 1.60 | Why? |
| Ascaris lumbricoides | 2 | 2018 | 11 | 1.51 | Why? |
| Ascariasis | 2 | 2018 | 21 | 1.48 | Why? |
| Disease Eradication | 10 | 2021 | 581 | 1.44 | Why? |
| Filaricides | 4 | 2021 | 41 | 1.25 | Why? |
| Helminthiasis | 5 | 2018 | 78 | 1.23 | Why? |
| Models, Theoretical | 19 | 2021 | 6659 | 1.22 | Why? |
| Leishmaniasis, Visceral | 3 | 2018 | 85 | 1.02 | Why? |
| Ancylostomatoidea | 1 | 2018 | 9 | 0.77 | Why? |
| Trichuris | 1 | 2018 | 23 | 0.77 | Why? |
| Trichuriasis | 1 | 2018 | 12 | 0.76 | Why? |
| Loiasis | 1 | 2018 | 7 | 0.76 | Why? |
| Schistosomiasis mansoni | 2 | 2021 | 35 | 0.76 | Why? |
| Hookworm Infections | 1 | 2018 | 16 | 0.76 | Why? |
| Yaws | 1 | 2018 | 5 | 0.75 | Why? |
| Diethylcarbamazine | 2 | 2018 | 11 | 0.73 | Why? |
| Schistosoma mansoni | 1 | 2018 | 27 | 0.72 | Why? |
| Onchocerciasis | 1 | 2018 | 64 | 0.67 | Why? |
| Diagnostic Tests, Routine | 2 | 2018 | 2643 | 0.62 | Why? |
| Microbiological Techniques | 1 | 2018 | 232 | 0.59 | Why? |
| Cost-Benefit Analysis | 4 | 2018 | 2259 | 0.55 | Why? |
| Communicable Diseases | 2 | 2020 | 2148 | 0.55 | Why? |
| Chemoprevention | 2 | 2018 | 585 | 0.53 | Why? |
| Models, Biological | 2 | 2020 | 4907 | 0.45 | Why? |
| Communicable Disease Control | 7 | 2021 | 29620 | 0.43 | Why? |
| User-Computer Interface | 1 | 2017 | 1068 | 0.40 | Why? |
| Data Collection | 2 | 2020 | 1769 | 0.40 | Why? |
| Drug Administration Schedule | 1 | 2016 | 2324 | 0.39 | Why? |
| Azithromycin | 3 | 2021 | 3943 | 0.38 | Why? |
| Albendazole | 2 | 2018 | 32 | 0.35 | Why? |
| Coinfection | 2 | 2018 | 6820 | 0.35 | Why? |
| Intestinal Diseases, Parasitic | 2 | 2018 | 34 | 0.34 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.33 | Why? |
| Epidemiological Monitoring | 2 | 2018 | 3493 | 0.31 | Why? |
| Soil | 2 | 2018 | 137 | 0.31 | Why? |
| Disease Transmission, Infectious | 3 | 2020 | 9044 | 0.30 | Why? |
| Contact Tracing | 5 | 2020 | 8448 | 0.30 | Why? |
| Leprosy | 2 | 2018 | 142 | 0.30 | Why? |
| Anti-Bacterial Agents | 4 | 2021 | 10083 | 0.28 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.27 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.26 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.26 | Why? |
| Endemic Diseases | 2 | 2018 | 480 | 0.26 | Why? |
| Models, Statistical | 5 | 2018 | 5312 | 0.26 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.26 | Why? |
| Microfilariae | 2 | 2018 | 5 | 0.24 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.23 | Why? |
| Computer Simulation | 4 | 2020 | 4982 | 0.22 | Why? |
| Helminths | 2 | 2018 | 60 | 0.21 | Why? |
| Schistosomiasis | 1 | 2021 | 59 | 0.21 | Why? |
| Ivermectin | 3 | 2018 | 973 | 0.20 | Why? |
| Insecticides | 2 | 2018 | 178 | 0.20 | Why? |
| Onchocerca | 1 | 2018 | 3 | 0.19 | Why? |
| Loa | 1 | 2018 | 4 | 0.19 | Why? |
| Tsetse Flies | 1 | 2018 | 4 | 0.19 | Why? |
| Phlebotomus | 1 | 2018 | 11 | 0.19 | Why? |
| Trypanosoma brucei gambiense | 1 | 2018 | 23 | 0.19 | Why? |
| Melanesia | 1 | 2018 | 15 | 0.19 | Why? |
| Insect Control | 1 | 2018 | 17 | 0.19 | Why? |
| Internet | 1 | 2017 | 6204 | 0.18 | Why? |
| Trypanosomiasis, African | 1 | 2018 | 31 | 0.18 | Why? |
| Life Cycle Stages | 1 | 2018 | 162 | 0.18 | Why? |
| Insecticide-Treated Bednets | 1 | 2018 | 77 | 0.18 | Why? |
| Mycobacterium leprae | 1 | 2017 | 20 | 0.18 | Why? |
| World Health Organization | 3 | 2021 | 4213 | 0.18 | Why? |
| Sri Lanka | 1 | 2018 | 241 | 0.17 | Why? |
| Insect Bites and Stings | 1 | 2018 | 63 | 0.17 | Why? |
| Rain | 1 | 2018 | 108 | 0.17 | Why? |
| Anopheles | 1 | 2018 | 89 | 0.17 | Why? |
| Humans | 40 | 2021 | 930598 | 0.16 | Why? |
| Evaluation Studies as Topic | 1 | 2018 | 391 | 0.16 | Why? |
| Animals | 13 | 2021 | 78931 | 0.16 | Why? |
| Insect Vectors | 1 | 2018 | 227 | 0.15 | Why? |
| Epidemiologic Studies | 1 | 2018 | 554 | 0.15 | Why? |
| Public Health | 5 | 2021 | 16359 | 0.15 | Why? |
| Mosquito Control | 1 | 2018 | 237 | 0.15 | Why? |
| Spatial Analysis | 2 | 2018 | 878 | 0.15 | Why? |
| Prevalence | 6 | 2021 | 25773 | 0.15 | Why? |
| Goals | 1 | 2018 | 335 | 0.14 | Why? |
| Mosquito Vectors | 1 | 2018 | 351 | 0.14 | Why? |
| Health Policy | 3 | 2020 | 6242 | 0.14 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2017 | 265 | 0.14 | Why? |
| Models, Economic | 1 | 2017 | 316 | 0.14 | Why? |
| Antiparasitic Agents | 1 | 2016 | 267 | 0.13 | Why? |
| Uganda | 1 | 2018 | 1057 | 0.13 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.12 | Why? |
| Immunity, Herd | 1 | 2020 | 1011 | 0.12 | Why? |
| Bangladesh | 1 | 2018 | 1620 | 0.12 | Why? |
| Geography | 1 | 2018 | 1801 | 0.12 | Why? |
| Spatio-Temporal Analysis | 1 | 2018 | 1182 | 0.12 | Why? |
| Population Health | 1 | 2018 | 504 | 0.11 | Why? |
| Child, Preschool | 4 | 2018 | 36283 | 0.11 | Why? |
| Nigeria | 1 | 2018 | 2292 | 0.10 | Why? |
| Gastrointestinal Tract | 1 | 2018 | 1113 | 0.10 | Why? |
| Software | 1 | 2020 | 2501 | 0.09 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.09 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.09 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.09 | Why? |
| Papua New Guinea | 2 | 2018 | 63 | 0.09 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.09 | Why? |
| Child | 5 | 2020 | 70012 | 0.08 | Why? |
| Rural Population | 1 | 2018 | 2408 | 0.08 | Why? |
| Infant | 2 | 2018 | 30274 | 0.07 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.07 | Why? |
| Republic of Korea | 1 | 2018 | 5858 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.07 | Why? |
| United Kingdom | 2 | 2021 | 18046 | 0.07 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Travel | 1 | 2021 | 7220 | 0.06 | Why? |
| Female | 8 | 2018 | 380317 | 0.06 | Why? |
| Schistosoma haematobium | 1 | 2021 | 35 | 0.06 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.05 | Why? |
| Mass Screening | 2 | 2018 | 8005 | 0.05 | Why? |
| Policy | 2 | 2018 | 1372 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Adolescent | 3 | 2018 | 86841 | 0.05 | Why? |
| Male | 6 | 2018 | 367725 | 0.05 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.05 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.04 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.04 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.04 | Why? |
| Leprostatic Agents | 1 | 2017 | 94 | 0.04 | Why? |
| Antiprotozoal Agents | 1 | 2017 | 83 | 0.04 | Why? |
| False Positive Reactions | 1 | 2021 | 1338 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Asia, Southeastern | 1 | 2017 | 390 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2017 | 511 | 0.03 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.03 | Why? |
| Global Health | 1 | 2016 | 13911 | 0.03 | Why? |
| Poverty Areas | 1 | 2017 | 556 | 0.03 | Why? |
| Adult | 3 | 2018 | 244371 | 0.03 | Why? |
| Reproduction | 1 | 2014 | 259 | 0.03 | Why? |
| Environment | 1 | 2018 | 769 | 0.03 | Why? |
| Incidence | 3 | 2018 | 25622 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Hygiene | 1 | 2018 | 987 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Population Dynamics | 1 | 2014 | 378 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| London | 1 | 2017 | 2166 | 0.03 | Why? |
| India | 2 | 2018 | 11875 | 0.02 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.02 | Why? |
| Health Care Costs | 1 | 2017 | 1007 | 0.02 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.02 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Africa | 1 | 2017 | 2986 | 0.02 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Schools | 1 | 2020 | 4187 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Aged | 1 | 2018 | 215776 | 0.01 | Why? |
| Middle Aged | 1 | 2018 | 270681 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.01 | Why? |
Hollingsworth's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(117)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_